Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MabVax Therapeutics Holdings Inc.
DescriptionDual VEGFR1 and VEGFR2 kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationColorectal cancer
Indication DetailsTreat colon cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today